Effects of theophylline on the expression of Bcl-2 and Bax protein in eosinophils in induced sputum of asthmatic patients

Li Liu,Jiong Yang,Ke Hu

2004-01-01

Abstract:Objective: To study whether low dose theophylline has an impact on the expression of protein-Bcl-2, Bax in eosinophils(Eos) in airway of asthmatic patients. Methods: 22 asthmatic subjects were administered orally controlled releasing theophylline tablets (Shufumei) 200 mg twice a day for 4 weeks, and several indexes were determined. Results: It showed that Bcl-2(+)Eos% in the induced sputum was significantly lower than that before the treatment (4.82 ± 2.82 vs 7.14 ± 3.51, P < 0.01) and Bax(+)Eos% was significantly higher than that before the treatment (6.09 ± 3.23 vs 1.59 ± 1.40, P < 0.01) after the treatment of theophylline for four weeks. The symptom scores decreased significantly(17 ± 1.43 vs 5.12 ± 1.47, P < 0.05). Conclusion: It is suggested that the administration of a low dose of oral theophylline in asthmatic patients seems to reduce the level of expression of protein-Bcl-2 and to increase the expression of protein-Bax. The level of expression of protein-Bcl-2 in eosinophils in the induced sputum may be applied as a marker of the severity of the asthma. Theophylline may reduce the airway inflammation by its effect on the apoptosis of airway eosinophils, and this mechanism may be in its influence in the apoptosis proteins.